Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DSC127 in Diabetic Foot Ulcers
NCT01849965Phase 3Terminated
- Sponsor
- Integra LifeSciences
- Start
- Apr 2013
- Primary completion
- Dec 2015
- Modality
- Peptides, Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial in diabetic foot ulcer (DFU) comparing DSC127, Vehicle gel and Standard of Care gel (3 arms). Primary endpoint: Proportion of subjects with complete wound closure at 10 weeks. Started Apr 2013; status: terminated.
02
Drugs
aclerastide
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT01849965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01849965.